Literature DB >> 29809131

Cerebellar high-grade gliomas do not present the same molecular alterations as supratentorial high-grade gliomas and may show histone H3 gene mutations.

Arnault Tauziède-Espariat, Raphaël Saffroy, Mélanie Pagès, Johan Pallud, Laurence Legrand, Aurore Besnard, Joëlle Lacombe, Guillaume Lot, Alin Borha, Sanaa Tazi, Homa Adle-Biassette, Marc Polivka, Emmanuèle Lechapt, Pascale Varlet.   

Abstract

Numerous molecular alterations have been described in supratentorial high-grade gliomas (1p19q co-deletion, IDH1/2, histone H3, hTERT promotor mutations, loss of ATRX) which have led to a new histomolecular classification of diffuse gliomas. We aimed at describing these alterations in a series of 19 adults with pure cerebellar high-grade gliomas. Systematic immunohistochemical analyses, including that of IDH1R132H, ATRX, p53, PTEN, EGFR, p16, FGFR3, BRAFV600E, mismatch repair proteins, H3K27me3, H3K36me3, and H3K27M; molecular analyses of IDH1/2, hTERT, BRAF, H3F3A, and HIST1H3B mutation hotspots; and EGFR, PTEN FISH were retrospectively performed in a multicentric study. We histopathologically identified 14 glioblastomas, 4 grade III astrocytomas and 1 gliosarcoma. Two cases showed a H3F3A K27M mutation. Only one case harbored a classical profile of glioblastoma with hTERT mutation, EGFR gain and 10q loss. The most frequent alteration was the absence of p16 immunoexpression. We report a histomolecular analysis of pure cerebellar high grade gliomas. The histomolecular profile appears to be different from that of supratentorial gliomas, with no IDH1/2 gene mutations and only 1 case with a classic profile of de novo glioblastoma. In 2 cases, we identified H3F3A K27M mutation, classically described in pediatric midline gliomas.
.

Entities:  

Mesh:

Substances:

Year:  2018        PMID: 29809131     DOI: 10.5414/NP301104

Source DB:  PubMed          Journal:  Clin Neuropathol        ISSN: 0722-5091            Impact factor:   1.368


  6 in total

1.  Treatment patterns and outcomes for cerebellar glioblastoma in the concomitant chemoradiation era: A National Cancer database study.

Authors:  Michael Zhang; Richard Li; Erqi L Pollom; Arya Amini; Savita Dandapani; Gordon Li
Journal:  J Clin Neurosci       Date:  2020-11-06       Impact factor: 1.961

2.  Management, functional outcomes and survival in a French multicentric series of 118 adult patients with cerebellar glioblastoma.

Authors:  Luc Bauchet; Jacques Guyotat; Thiébaud Picart; David Meyronet; Johan Pallud; Chloé Dumot; Philippe Metellus; Sonia Zouaoui; Moncef Berhouma; François Ducray
Journal:  J Cancer Res Clin Oncol       Date:  2021-01-05       Impact factor: 4.553

Review 3.  Diagnostic test accuracy and cost-effectiveness of tests for codeletion of chromosomal arms 1p and 19q in people with glioma.

Authors:  Alexandra McAleenan; Hayley E Jones; Ashleigh Kernohan; Tomos Robinson; Lena Schmidt; Sarah Dawson; Claire Kelly; Emmelyn Spencer Leal; Claire L Faulkner; Abigail Palmer; Christopher Wragg; Sarah Jefferies; Sebastian Brandner; Luke Vale; Julian Pt Higgins; Kathreena M Kurian
Journal:  Cochrane Database Syst Rev       Date:  2022-03-02

4.  Primary cerebellar glioblastomas in children: clinical presentation and management.

Authors:  Qiguang Wang; Jian Cheng; Zhang Si; Wenke Liu; Xuhui Hui; Qiang Li; Yan Ju
Journal:  Neurosurg Rev       Date:  2020-08-26       Impact factor: 3.042

5.  Rapid Brainstem Infiltration of a Cerebellar Glioblastoma.

Authors:  Orlando De Jesus; Juan Vigo; María Oliver-Ricart; Juan L Pérez-Berenguer
Journal:  Cureus       Date:  2022-02-27

6.  Discernable differences in the genetic and molecular profile of cerebellar glioblastoma.

Authors:  Muhibullah S Tora; D Cory Adamson
Journal:  Transl Cancer Res       Date:  2019-12       Impact factor: 1.241

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.